These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 21216871)

  • 1. Migraine preventive drug-induced weight gain may be mediated by effects on hypothalamic peptides: the results of a pilot study.
    Caproni S; Corbelli I; Pini LA; Cupini ML; Calabresi P; Sarchielli P
    Cephalalgia; 2011 Apr; 31(5):543-9. PubMed ID: 21216871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of amitriptyline and flunarizine on weight gain and serum leptin, C peptide and insulin levels when used as migraine preventive treatment.
    Berilgen MS; Bulut S; Gonen M; Tekatas A; Dag E; Mungen B
    Cephalalgia; 2005 Nov; 25(11):1048-53. PubMed ID: 16232156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of migraine using flunarizine (results of a pilot study using Amalium)].
    Wessely P; Holzner F
    Wien Med Wochenschr; 1987 Jan; 137(1):21-6. PubMed ID: 3590812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open pilot study assessing the benefits of quetiapine for the prevention of migraine refractory to the combination of atenolol, nortriptyline, and flunarizine.
    Krymchantowski AV; Jevoux C; Moreira PF
    Pain Med; 2010 Jan; 11(1):48-52. PubMed ID: 20002594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight change and clinical markers of cardiovascular disease risk during preventive treatment of migraine.
    Bigal ME; Lipton RB; Biondi DM; Xiang J; Hulihan J
    Cephalalgia; 2009 Nov; 29(11):1188-96. PubMed ID: 19558539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine.
    Gawel MJ; Kreeft J; Nelson RF; Simard D; Arnott WS
    Can J Neurol Sci; 1992 Aug; 19(3):340-5. PubMed ID: 1393843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective prophylactic treatments of migraine lower plasma glutamate levels.
    Ferrari A; Spaccapelo L; Pinetti D; Tacchi R; Bertolini A
    Cephalalgia; 2009 Apr; 29(4):423-9. PubMed ID: 19170689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amitriptyline vs divalproate in migraine prophylaxis: a randomized controlled trial.
    Kalita J; Bhoi SK; Misra UK
    Acta Neurol Scand; 2013 Jul; 128(1):65-72. PubMed ID: 23406477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of amitriptyline and flunarizine on catecholamine response to light in patients with migraine.
    Stoica E; Enulescu O
    Rom J Neurol Psychiatry; 1993; 31(1):11-9. PubMed ID: 8363973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two different doses of amitriptyline ER in the prophylaxis of migraine: long-term results and predictive factors.
    Lampl C; Huber G; Adl J; Luthringshausen G; Franz G; Marecek S; Weber J; Baumhackl U; Mueller T
    Eur J Neurol; 2009 Aug; 16(8):943-8. PubMed ID: 19456855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allodynia in migraine: clinical observation and role of prophylactic therapy.
    Misra UK; Kalita J; Bhoi SK
    Clin J Pain; 2013 Jul; 29(7):577-82. PubMed ID: 23328330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flunarizine for prophylactic treatment of childhood migraine.
    Visudtibhan A; Lusawat A; Chiemchanya S; Visudhiphan P
    J Med Assoc Thai; 2004 Dec; 87(12):1466-70. PubMed ID: 15822542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight change associated with the use of migraine-preventive medications.
    Taylor FR
    Clin Ther; 2008 Jun; 30(6):1069-80. PubMed ID: 18640463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flunarizine in migraine prophylaxis: efficacy and tolerability of 5 mg and 10 mg dose levels.
    Centonze V; Magrone D; Vino M; Caporaletti P; Attolini E; Campanale G; Albano O
    Cephalalgia; 1990 Feb; 10(1):17-24. PubMed ID: 2317849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid.
    Sarchielli P; Rainero I; Coppola F; Rossi C; Mancini M; Pinessi L; Calabresi P
    Cephalalgia; 2008 Jul; 28(7):714-22. PubMed ID: 18479471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive treatment of migraine: effect on weight.
    Young WB; Rozen TD
    Cephalalgia; 2005 Jan; 25(1):1-11. PubMed ID: 15606563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rejection and acceptance of possible side effects of migraine prophylactic drugs.
    Kowacs PA; Piovesan EJ; Tepper SJ
    Headache; 2009 Jul; 49(7):1022-7. PubMed ID: 19438733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of flunarizine in the prophylaxis of migraine: a meta-analytical review of the literature].
    Reveiz-Herault L; Cardona AF; Ospina EG; Carrillo P
    Rev Neurol; 2003 May 16-31; 36(10):907-12. PubMed ID: 12766861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraine.
    Verspeelt J; De Locht P; Amery WK
    Cephalalgia; 1996 Aug; 16(5):328-36; discussion 288. PubMed ID: 8869768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Flunarizine in the prevention of the migraine crisis of classic and common headache].
    Pini LA; Ferrari A; Bergonzini G; Sternieri E
    Minerva Med; 1987 Jul; 78(14):1097-8. PubMed ID: 3601158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.